TearLab is an in-vitro diagnostic company, which develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. TearLab offers TearLab Osmolority System, which is intended to measure the osmolarity of human tears to aid in the diagnosis of dry eye disease in patients suspected of having dry eye disease, in conjunction with other methods of clinical evaluation.

Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
2003
Size (employees)
75 (est)
TearLab was founded in 2003 and is headquartered in San Diego, US

TearLab Office Locations

TearLab has an office in San Diego
San Diego, US (HQ)
100 9980 Huennekens St
Show all (1)

TearLab Financials and Metrics

TearLab Financials

TearLab's revenue was reported to be $28 m in FY, 2016
USD

Revenue (Q2, 2017)

7 m

Gross profit (Q2, 2017)

4.3 m

Gross profit margin (Q2, 2017), %

62%

EBIT (Q2, 2017)

(2.8 m)

Market capitalization (09-Nov-2017)

4 m

Cash (30-Jun-2017)

10.2 m

EV

21.1 m
TearLab's current market capitalization is $4 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

14.6 m19.7 m25.2 m28 m

Revenue growth, %

35%28%11%

Cost of goods sold

8.1 m8.8 m10.8 m10.2 m

Gross profit

6.5 m10.9 m14.3 m17.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

4.2 m4.2 m5 m5.2 m5.4 m6.3 m6.6 m6.8 m6.9 m7.2 m6.7 m7 m

Cost of goods sold

2.3 m2.2 m2.5 m2.7 m2.4 m2.8 m2.8 m2.5 m2.5 m2.6 m2.7 m

Gross profit

1.9 m2 m2.5 m2.5 m3 m3.5 m3.8 m4.2 m4.4 m4.7 m4.3 m

Gross profit Margin, %

46%48%51%48%56%56%57%62%64%65%62%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

37.8 m16.3 m13.8 m15.5 m

Accounts Receivable

3.5 m2.5 m3 m2.3 m

Inventories

885 k790 k3.2 m

Current Assets

42.9 m22.7 m21.6 m22.2 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

42 m32 m25.6 m20.7 m23.3 m15.9 m10.6 m7.2 m20.1 m17.5 m13 m10.2 m

Accounts Receivable

3.4 m3.1 m3 m3.1 m2.3 m2.2 m2.4 m3 m2.3 m2.4 m2.3 m2.1 m

Inventories

959 k1.2 m2.3 m3.5 m3.2 m3.8 m4 m3.6 m3.3 m3.4 m3.3 m2.9 m

Current Assets

46.8 m36.9 m31.4 m28.1 m29.8 m22.7 m17.9 m15.1 m26.8 m24.2 m19.8 m16.3 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Depreciation and Amortization

1.5 m1.1 m

Accounts Receivable

742 k

Inventories

780 k

Accounts Payable

(335 k)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Depreciation and Amortization

395 k382 k382 k382 k382 k304 k382 k359 k

Accounts Receivable

3 m3.1 m2.3 m2.2 m2.4 m(5 k)2.3 m2.4 m2.3 m

Inventories

2.3 m3.5 m3.2 m3.8 m4 m338 k3.3 m3.4 m3.3 m

Accounts Payable

667 k1.8 m2.5 m1.9 m3.1 m721 k2.3 m1.9 m2.7 m
Y, 2017

EV/EBIT

-7.4 x
Show all financial metrics

TearLab Market Value History

TearLab's Web-traffic and Trends

TearLab Online and Social Media Presence

TearLab Company Life and Culture

You may also be interested in